BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38072817)

  • 1. Metal-Organic Framework-Mediated Synergistic Hypoxia-Activated Chemo-Immunotherapy Induced by High Intensity Focused Ultrasound for Enhanced Cancer Theranostics.
    Sun T; Li J; Zhou Y; Zeng C; Luo C; Luo X; Li H
    Small; 2024 May; 20(18):e2306338. PubMed ID: 38072817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banoxantrone Coordinated Metal-Organic Framework for Photoacoustic Imaging-Guided High Intensity Focused Ultrasound Therapy.
    Sun T; Li J; Zeng C; Luo C; Luo X; Li H
    Adv Healthc Mater; 2023 Jan; 12(2):e2202348. PubMed ID: 36281898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
    Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
    Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy.
    Tang R; He H; Lin X; Wu N; Wan L; Chen Q; Hu Y; Cheng C; Cao Y; Guo X; Zhou Y; Xiong X; Zheng M; Wang Q; Li F; Zhou Y; Li P
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36650023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Mechanical High-Intensity Focused Ultrasound Ablation with Chemotherapy for Augmentation of Anticancer Immune Responses.
    Li C; Lu Y; Cheng L; Zhang X; Yue J; Liu J
    Mol Pharm; 2021 May; 18(5):2091-2103. PubMed ID: 33886331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.
    Zhang N; Wang R; Hao J; Yang Y; Zou H; Wang Z
    Int J Nanomedicine; 2017; 12():7273-7289. PubMed ID: 29042775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Targeted, Responsive, and Synergistic Cancer Nanotheranostics by Magnetic Resonance Imaging-Guided Synergistic High-Intensity Focused Ultrasound Ablation and Chemotherapy.
    Tang H; Guo Y; Peng L; Fang H; Wang Z; Zheng Y; Ran H; Chen Y
    ACS Appl Mater Interfaces; 2018 May; 10(18):15428-15441. PubMed ID: 29652130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
    Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
    Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Study of Tumor Therapy Mediated by Multimodal Imaging Based on a Biological Targeting Synergistic Agent.
    Wang Y; Chen C; Luo Y; Xiong J; Tang Y; Yang H; Wang L; Jiang F; Gao X; Xu D; Li H; Wang Q; Zou J
    Int J Nanomedicine; 2020; 15():1871-1888. PubMed ID: 32256065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Microenvironment-Triggered Ion Exchange of a Metal-Organic Framework Hybrid for Multimodal Imaging and Synergistic Therapy of Tumors.
    Chen Y; Li ZH; Pan P; Hu JJ; Cheng SX; Zhang XZ
    Adv Mater; 2020 Jun; 32(24):e2001452. PubMed ID: 32374492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
    Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
    J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo.
    Wu L; Zhou J; Zhou W; Huang XF; Chen Q; Wang W; Zhai L; Li S; Tang Z
    Pathol Res Pract; 2021 Apr; 220():153270. PubMed ID: 33640712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-Demand Detaching Nanosystem for the Spatiotemporal Control of Cancer Theranostics.
    Liu T; Wan Q; Luo Y; Chen M; Zou C; Ma M; Liu X; Chen H
    ACS Appl Mater Interfaces; 2019 May; 11(18):16285-16295. PubMed ID: 30986025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Catalytic Generation of O
    Liu T; Zhang N; Wang Z; Wu M; Chen Y; Ma M; Chen H; Shi J
    ACS Nano; 2017 Sep; 11(9):9093-9102. PubMed ID: 28796487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of Upconverted Metal-Organic Frameworks for Near-Infrared Light-Triggered Combinational Photodynamic/Chemo-/Immunotherapy against Hypoxic Tumors.
    Shao Y; Liu B; Di Z; Zhang G; Sun LD; Li L; Yan CH
    J Am Chem Soc; 2020 Feb; 142(8):3939-3946. PubMed ID: 31968933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Intensity Focused Ultrasound-Responsive and Ultrastable Cerasomal Perfluorocarbon Nanodroplets for Alleviating Tumor Multidrug Resistance and Epithelial-Mesenchymal Transition.
    Ma X; Yao M; Shi J; Li X; Gao Y; Luo Q; Hou R; Liang X; Wang F
    ACS Nano; 2020 Nov; 14(11):15904-15918. PubMed ID: 33175487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery.
    Chen Y; Chen H; Shi J
    Adv Healthc Mater; 2015 Jan; 4(1):158-65. PubMed ID: 24898413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.